PAX2 and neoplasm: We propose that pathways involving TGF-β1 signalling, and subsequent down-regulation of PAX2 expression facilitate the switching of tumor cells from PAX2-mediated epithelial cell differentiation to more stem cell-like mesenchymal programs.